Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Galmed closes patient enrolment for Phase IIb ARREST study of Aramchol to treat liver diseases

Go Top